Product Code: VMR11211227
Value Market Research deeply researched the Global Cancer Immunotherapy Drug Discovery Outsourcing Market to foresee a significant growth in the industry over the upcoming years. The global cancer immunotherapy drug discovery outsourcing market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.
The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global cancer immunotherapy drug discovery outsourcing market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this cancer immunotherapy drug discovery outsourcing market.
The next sections of the cancer immunotherapy drug discovery outsourcing market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.
Countries Covered in the report are as below:
- North America: United States, Canada, and Mexico
- Europe: United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe
- Asia-Pacific: China, India, Japan, South Korea, Australia & Rest of APAC
- Latin America: Brazil, Argentina, Peru, Chile & Rest of Latin America
- Middle East and Africa: Saudi Arabia, UAE, Israel, South Africa
Market Segmentation in the report is as below:
By Drug Type
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies And Cancer Vaccines
- Others
By Service Type
- Target Identification And Validation
- Lead Screening And Characterization
- Cell Based Assays
By Cancer Type
- Lung
- Breast
- Colorectal
- Melanoma
- Prostate
- Head And Neck
- Ovarian
- Pancreatic
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Cancer Immunotherapy Drug Discovery Outsourcing Market
- 2.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Snapshot
3 . CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING - INDUSTRY ANALYSIS
- 3.1. Introduction
- 3.2. Market Drivers of Cancer Immunotherapy Drug Discovery Outsourcing Market
- 3.3. Market Restraints of Cancer Immunotherapy Drug Discovery Outsourcing Market
- 3.4. Opportunities of Cancer Immunotherapy Drug Discovery Outsourcing Market
- 3.5. Trends of Cancer Immunotherapy Drug Discovery Outsourcing Market
- 3.6. Porter's Five Force Analysis of Cancer Immunotherapy Drug Discovery Outsourcing Market
- 3.7. Cancer Immunotherapy Drug Discovery Outsourcing Market Attractiveness Analysis
- 3.7.1 Market Attractive Analysis by Drug Type
- 3.7.2 Market Attractive Analysis by Service Type
- 3.7.3 Market Attractive Analysis by Cancer Type
- 3.7.4 Market Attractive Analysis by Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Cancer Immunotherapy Drug Discovery Outsourcing Value Chain Analysis
- 4.2. Cancer Immunotherapy Drug Discovery Outsourcing Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Cancer Immunotherapy Drug Discovery Outsourcing Raw Material Manufactures List
- 4.2.3. Price Trend of Cancer Immunotherapy Drug Discovery Outsourcing Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY DRUG TYPE
- 5.1 Overview by Drug Type
- 5.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Drug Type
- 5.3 Market Analysis of Monoclonal Antibodies by Regions
- 5.4 Market Analysis of Immunomodulators by Regions
- 5.5 Market Analysis of Oncolytic Viral Therapies And Cancer Vaccines by Regions
- 5.6 Market Analysis of Others by Regions
6 . GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY SERVICE TYPE
- 6.1 Overview by Service Type
- 6.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Service Type
- 6.3 Market Analysis of Target Identification And Validation by Regions
- 6.4 Market Analysis of Lead Screening And Characterization by Regions
- 6.5 Market Analysis of Cell Based Assays by Regions
7 . GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY CANCER TYPE
- 7.1 Overview by Cancer Type
- 7.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis by Cancer Type
- 7.3 Market Analysis of Lung by Regions
- 7.4 Market Analysis of Breast by Regions
- 7.5 Market Analysis of Colorectal by Regions
- 7.6 Market Analysis of Melanoma by Regions
- 7.7 Market Analysis of Prostate by Regions
- 7.8 Market Analysis of Head And Neck by Regions
- 7.9 Market Analysis of Ovarian by Regions
- 7.10. Market Analysis of Pancreatic by Regions
8 . GLOBAL CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING MARKET ANALYSIS BY GEOGRAPHY
- 8.1. Regional Outlook
- 8.2. Introduction
- 8.3. North America
- 8.3.1. Overview
- 8.3.2. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
- 8.3.3. United State
- 8.3.4. Rest of North America
- 8.4. Europe
- 8.4.1. Overview
- 8.4.2. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Market Segment
- 8.4.3. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
- 8.4.4. United Kingdom
- 8.4.5. France
- 8.4.6. Germany
- 8.4.7 Rest of Europe
- 8.5. Asia Pacific
- 8.5.1. Overview
- 8.5.2. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Market Segment
- 8.5.3. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
- 8.5.4. China
- 8.5.5. Japan
- 8.5.6. India
- 8.5.7. Rest of Asia Pacific
- 8.6. Latin America
- 8.6.1. Overview
- 8.6.2. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Market Segment
- 8.6.3. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
- 8.6.4. Brazil
- 8.6.5. Rest of Latin America
- 8.7. Middle East & Africa
- 8.7.1. Overview
- 8.7.2. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Market Segment
- 8.7.3. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Estimate by Country
- 8.7.4. Middle East
- 8.7.5. Africa
9 . COMPETITIVE LANDSCAPE OF THE CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING COMPANIES
- 9.1. Cancer Immunotherapy Drug Discovery Outsourcing Market Competition
- 9.2. Partnership/Collaboration/Agreement
- 9.3. Merger And Acquisitions
- 9.4. New Product Launch
- 9.5. Other Developments
10 . COMPANY PROFILES OF CANCER IMMUNOTHERAPY DRUG DISCOVERY OUTSOURCING INDUSTRY
- 10.1. Company Share Analysis
- 10.2. Market Concentration Rate
- 10.3. Aquila BioMedical
- 10.3.1. Company Overview
- 10.3.2. Financials
- 10.3.3. Products
- 10.3.4. Recent Developments
- 10.4. BPS Bioscience, Inc.
- 10.4.1. Company Overview
- 10.4.2. Financials
- 10.4.3. Products
- 10.4.4. Recent Developments
- 10.5. Celentyx Ltd.
- 10.5.1. Company Overview
- 10.5.2. Financials
- 10.5.3. Products
- 10.5.4. Recent Developments
- 10.6. Covance, Inc.
- 10.6.1. Company Overview
- 10.6.2. Financials
- 10.6.3. Products
- 10.6.4. Recent Developments
- 10.7. Crown Bioscience, Inc.
- 10.7.1. Company Overview
- 10.7.2. Financials
- 10.7.3. Products
- 10.7.4. Recent Developments
- 10.8. DiscoverX Corporation
- 10.8.1. Company Overview
- 10.8.2. Financials
- 10.8.3. Products
- 10.8.4. Recent Developments
- 10.9. Explicyte
- 10.9.1. Company Overview
- 10.9.2. Financials
- 10.9.3. Products
- 10.9.4. Recent Developments
- 10.10. Genscript Biotech Corporation
- 10.10.1. Company Overview
- 10.10.2. Financials
- 10.10.3. Products
- 10.10.4. Recent Developments
- 10.11. HD Biosciences Co., Ltd.
- 10.11.1. Company Overview
- 10.11.2. Financials
- 10.11.3. Products
- 10.11.4. Recent Developments
- 10.12. Horizon Discovery Group PLC
- 10.12.1. Company Overview
- 10.12.2. Financials
- 10.12.3. Products
- 10.12.4. Recent Developments
- 10.13. ImmunXperts SA
- 10.13.1. Company Overview
- 10.13.2. Financials
- 10.13.3. Products
- 10.13.4. Recent Developments
- 10.14. Molecular Imaging, Inc.
- 10.14.1. Company Overview
- 10.14.2. Financials
- 10.14.3. Products
- 10.14.4. Recent Developments
- 10.15. Personalis, Inc.
- 10.15.1. Company Overview
- 10.15.2. Financials
- 10.15.3. Products
- 10.15.4. Recent Developments
- 10.16. Promega Corporation
- 10.16.1. Company Overview
- 10.16.2. Financials
- 10.16.3. Products
- 10.16.4. Recent Developments
- 10.17. STC Biologics
- 10.17.1. Company Overview
- 10.17.2. Financials
- 10.17.3. Products
- 10.17.4. Recent Developments
11. IMPACT ANALYSIS OF COVID-19 OUTBREAK
- 11.1. Impact Analysis of Covid-19 Outbreak on the Market
- 11.1.1. Direct Impact on Production
- 11.1.2. Supply Chain and Market Disruption
- 11.1.3. Financial Impact on Firms and Financial Markets
- 11.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
- 11.3. Pre V/S Post COVID-19 Market
- 11.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
- 11.5. COVID-19: Micro and Macro Factor Analysis on the Market
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies